NEW YORK, NY / ACCESSWIRE / July 2, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.
Grand Canyon Education, Inc. (LOPE)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/grand-canyon-education-inc-loss-submission-form?prid=7754&wire=1
Lead Plaintiff Deadline: July 13, 2020
Class Period: January 5, 2018 - January 27, 2020
According to a filed complaint, statements made by Defendants were false and/or misleading because, following Grand Canyon's spin-off of its educational assets as Grand Canyon University ("GCU"): (i) GCU would not be a proper non-profit organization as it would remain under the control of Grand Canyon, and (ii) Grand Canyon would not be a third-party service provider to GCU but rather would continue to effectively operate the entity, and (iii) Grand Canyon employees served as executives of GCU and (iv) GCU functioned as an off-balance-sheet entity to which Grand Canyon would be able to funnel expenses and costs in exchange for a disproportionate amount of revenue, thereby inflating Grand Canyon's financial results.
Conn's, Inc. (CONN)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/conns-inc-loss-submission-form?prid=7754&wire=1
Lead Plaintiff Deadline: July 14, 2020
Class Period: September 3, 2019 - December 9, 2019
Allegations against CONN include that: (1) Conn's was experiencing an increase in first payment defaults and 60-plus day delinquencies; (2) as a result, Conn's was reasonably likely to record an increase to its provision for bad debts; (3) the Company made certain underwriting adjustments, including tightening its standards for new customers and online applicants; (4) as a result, the Company's same-store sales would be adversely impacted; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
CytomX Therapeutics, Inc. (CTMX)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/cytomx-therapeutics-inc-loss-submission-form?prid=7754&wire=1
Lead Plaintiff Deadline: July 20, 2020
Class Period: May 17, 2018 - May 13, 2020
Allegations against CTMX include that: (i) CytomX had downplayed issues with CX-072's efficacy observed in the PROCLAIM-CX-072 clinical program; (ii) CytomX had similarly downplayed issues with CX-2009's efficacy and safety observed in the PROCLAIM-CX-2009 clinical program; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.
To learn more contact Vincent Wong, Esq. either via email email@example.com or by telephone at 212.425.1140.
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
Vincent Wong, Esq.
39 East Broadway
New York, NY 10002
SOURCE: The Law Offices of Vincent Wong
View source version on accesswire.com: